Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepakro Syrup
- Development stage
- Unknown
- Lead developer
- Croise Pharma
- Administration
- Oral
01
Overview
Hepakro Syrup is an Ayurvedic hepatoprotective formulation developed and marketed by Croise Pharma. It is a proprietary blend of traditional Ayurvedic herbs, including Kalmegh (*Andrographis paniculata*), Kutki (*Picrorhiza kurroa*), Sarapunkha (*Tephrosia purpurea*), and Bhringraj (*Eclipta alba*). The syrup is designed to support liver health, promote detoxification, stimulate bile secretion, and improve overall metabolism. It is used to manage various liver disorders such as fatty liver, hepatitis, cirrhosis, jaundice, and toxin-induced liver damage.
- Brand names
- Hepakro Syrup
- Other names
- HEPAKRO SyrupHepakro-DS Syrup
Beyond the preview
Go deeper on Hepakro Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepakro Syrup.